SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is trending as a multichain meme coin, highlighted by its presence across Solana, BSC, CRO, and Ethereum (BASE) via Layerzero technology and an active deflationary burn mechanism. The engaged community touts its organic growth and partnerships, encouraging wider adoption of the asset.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as escalating global geopolitical tensions amplify the urgent demand for secure Western heavy rare earth supplies essential for defense and technology. The community is actively debating the strategic significance and potential undervaluation of CRML's Tanbreez project, while awaiting its Bankable Feasibility Study update and noting dynamic short interest.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community celebrates the confirmed departure of a prominent FDA official, widely perceived as a significant barrier to the approval of its Duchenne Muscular Dystrophy therapy, Deramiocel. This development, alongside high anticipation for a late-breaking Phase 3 data presentation at a major medical conference, is fueling intense bullish sentiment and expectations for a rapid regulatory decision.

Portillo's, Inc. serves street food through high-energy, multichannel restaurants designed to ignite the senses and create a memorable dining experience. The company was founded on June 8, 2021 and is headquartered in Oak Brook, IL.

Portillos Inc - Ordinary Shares - Class A

Portillo's is a hot topic following its Q4 '25 earnings, which indicated a drop in same-store sales, and the recent appointment of a new CEO. While many in the community believe the iconic brand is deeply undervalued and poised for a rebound due to strong customer loyalty and successful new location performance, others criticize management's strategy and the ongoing challenges of the restaurant sector.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin (CRO) is trending as the community anticipates potential ETF developments, specifically a dedicated CRO ETF and significant allocation in a rumored Trump Media Bitcoin ETF, driving strong bullish sentiment despite ongoing debates surrounding the token's past performance and management decisions.

Direxion Shares ETF Trust - Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

GUSH is trending amidst escalating Middle East tensions, particularly concerning potential Strait of Hormuz disruptions and regional conflict, which is fueling a "war trade" narrative among many. However, a frustrated segment of the community is actively debating the leveraged ETF's underperformance relative to broader crude oil price movements.

Almonty Industries, Inc. engages in mining, processing and shipment of tungsten concentrates. Its projects include Los Santos, Valtreixal, Almonty Korea Tungsten, Almonty Korea Moly, and Panasquiera. The company was founded on September 28, 2009 and is headquartered in Toronto, Canada.

Almonty Industries Inc

Almonty Industries is gaining significant attention due to multiple analyst upgrades and a parabolic rise in non-China tungsten prices, reflecting its pivotal role in critical mineral supply chains. The community is highly bullish, anticipating further upside as the company's major Sangdong mine approaches full production and amidst increasing global demand for secure, non-Chinese tungsten sources essential for defense and technology.

IBEX Ltd. is a business process outsourcing company, which engages in technology-enabled customer lifecycle experience solutions. It also specializes in digital marketing, lead generation, online sales, optimization, lead conversion, customer service, billing support, technical support, multi-lingual, omni-channel, retention, renewals, up and cross sell, and win-backs. The company was founded in 1984 and is headquartered in Washington, DC.

IBEX Ltd

IBEX Ltd. is gaining attention following robust financial results that include record quarterly growth and an upward revision to its fiscal year revenue and adjusted EBITDA guidance. The community is actively discussing its strong fundamentals, strategic focus on AI-powered customer experience, share buybacks, and perceived undervaluation, anticipating further upside.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending sharply on reports of an unexpected partnership with Novo Nordisk to sell GLP-1 weight-loss drugs, potentially ending a contentious lawsuit. The community is actively discussing the high short interest, anticipating a significant short squeeze fueled by this major catalyst.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile is trending due to mixed reactions to its latest earnings report, which highlighted revenue growth but also subscriber additions that fell short of some estimates, coupled with the announcement of a substantial share buyback program. The community is actively debating its valuation amidst competitive pressures, new AI-powered translation services, and partnerships for 6G development, while also noting recent institutional selling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Royce & Associates LP Takes Position in Zevra Therapeutics, Inc. $ZVRA

Royce & Associates LP acquired a new position in Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the...

Stevanato Group (STVN) Surpasses Q4 Earnings and Revenue Estimates

Stevanato (STVN) delivered earnings and revenue surprises of +6.06% and +4.96%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Zevra Therapeutics (ZVRA) Expected to Announce Quarterly Earnings on Tuesday

Zevra Therapeutics (NASDAQ:ZVRA) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 10. (View Earnings Report at...

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

Aclaris (ACRS) delivered earnings and revenue surprises of -9.59% and -33.04%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates

Ironwood (IRWD) delivered earnings and revenue surprises of -150.00% and -9.62%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eight analysts that are currently covering the company, MarketBeat...

Zevra Therapeutics Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Zevra Therapeutics, Inc. (NASDAQ: ZVRA). The investigation focuses on Zevras executive officers and whether investor...

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Short Interest Update

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 30th, there was short interest totaling...

Timothy Sangiovanni Sells 3,000 Shares of Zevra Therapeutics (NASDAQ:ZVRA) Stock

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Get Free Report) SVP Timothy Sangiovanni sold 3,000 shares of the company's stock in a transaction dated Tuesday, February 3rd. The shares were sold at an...

Neil Mcfarlane Sells 91,000 Shares of Zevra Therapeutics (NASDAQ:ZVRA) Stock

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Get Free Report) CEO Neil Mcfarlane sold 91,000 shares of the firm's stock in a transaction dated Monday, February 2nd. The stock was sold at an average price...

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Current Price	$8.98
Prev Close	$8.79
Open	$8.71
Dividend Yield	0.00%
50-Day Moving Average	$8.78
Beta	0.89
Avg. Volume	717,753.32
PE Ratio	13.93

52-Week High	$13.16
52-Week Low	$6.19
Market Capitalization	$494.86M
EPS (Annual)	-$2.28
Price to Book	3.71
Revenue Per Employee	$400,203.39

ZVRA
Zevra Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ZVRA News

ZVRAZevra Therapeutics Inc